Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.00
Bid: 98.80
Ask: 99.80
Change: 1.00 (1.02%)
Spread: 1.00 (1.012%)
Open: 99.60
High: 99.80
Low: 99.00
Prev. Close: 98.00
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Paper Production Issues

7 Sep 2010 09:51

RNS Number : 2665S
De La Rue PLC
07 September 2010
 



7 September 2010

DE LA RUE PLC

UPDATE ON PAPER PRODUCTION ISSUES

 

De La Rue plc (the "Company") announces further developments in its investigation of the irregularities identified at one of its paper production facilities.

 

The Board continues to carry out its investigations of the irregularities, assisted by its external legal advisers. However, it has now been established that some of the Company's employees have deliberately falsified certain paper specification test certificates for a limited number of customers. Banknote paper specifications have a large number of detailed parameters and the investigation has found in certain cases that a small number of them have fallen marginally short of specification.

 

The Board stopped shipment of any affected banknote paper as soon as it became aware of the irregularities. All production is now within specification and the Company is ready, subject to customer agreement, to resume supply of fully compliant paper. The Company remains confident that neither the physical security nor the security features in the paper have been compromised.

 

Furthermore, the Company can now report that these matters have already resulted in increased operating costs and lower volumes. The Board believes that, for the first half of the current financial year, the adverse impact on the group's profit before tax is likely to be at least £35m. This includes some one-off costs such as stock write-offs, professional fees, rectification and production trial costs as well as some slippage of Currency volumes into the second half.

 

The Company has reported its findings to the relevant law enforcement agencies. Quantification of the financial impact on the group for the full year and subsequent years is not possible at this stage pending the outcome of discussions with customers and the relevant law enforcement bodies.

 

Nicholas Brookes, Executive Chairman of De La Rue, said:

 

"The behaviour of some of our employees in this matter was totally unacceptable and contravened De La Rue's rigorous standards. We do not tolerate such behaviour and appropriate disciplinary action is being taken. The Board has put an immediate end to the irregularities that have been identified and has appointed a new Managing Director for the Currency Division.

 

"We are carrying out a very thorough investigation and are keeping our customers and the legal authorities fully informed. The Company reiterates that it has not found anything to suggest that either the physical security or the security features in the paper have been compromised and that the matters uncovered relate only to the certification of paper specifications at the relevant facility."

 

 

Enquiries

 

Richard Mountain/Andrew Lorenz Financial Dynamics +44 (0)207 269 7291

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIGDCRSGBGGR
Date   Source Headline
30th May 20247:00 amRNSStrategic Update
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.